300
Views
8
CrossRef citations to date
0
Altmetric
Drug Profile

Iron (III) isomaltoside 1000

, &
Pages 239-246 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jürgen Stein, Andreas Walper, Wolfgang Klemm, Karima Farrag, Ayşegül Aksan & Axel Dignass. (2018) Safety and efficacy of intravenous iron isomaltoside for correction of anaemia in patients with inflammatory bowel disease in everyday clinical practice. Scandinavian Journal of Gastroenterology 53:9, pages 1059-1065.
Read now

Articles from other publishers (7)

Lu Yun, Zhu YuMei, Vallish BN, Qingu Tang & Chang Feng. (2023) The Efficacy, Safety, and Economic Outcomes of Using Ferric Derisomaltose for the Management of Iron Deficiency in China: A Rapid Health Technology Assessment. Cureus.
Crossref
Benedikt Schaefer, Moritz Tobiasch, André Viveiros, Herbert Tilg, Nicholas A. Kennedy, Myles Wolf & Heinz Zoller. (2020) Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside—a systematic review and meta‐analysis. British Journal of Clinical Pharmacology 87:5, pages 2256-2273.
Crossref
Faisal Nuhu, Anne-Marie Seymour & Sunil Bhandari. (2019) Impact of Intravenous Iron on Oxidative Stress and Mitochondrial Function in Experimental Chronic Kidney Disease. Antioxidants 8:10, pages 498.
Crossref
Elpis Mantadakis. (2016) Advances in Pediatric Intravenous Iron Therapy. Pediatric Blood & Cancer 63:1, pages 11-16.
Crossref
Jacques Rottembourg & Guy Rostoker. (2015) Utilisation des dérivés injectables du fer au cours de la maladie rénale chronique : intérêts, limites et conseils pour un bon usage. Néphrologie & Thérapeutique 11:7, pages 531-542.
Crossref
Derek S. Larson & Daniel W. Coyne. (2014) Update on intravenous iron choices. Current Opinion in Nephrology and Hypertension 23:2, pages 186-191.
Crossref
Fernando Gomollón & Javier P. Gisbert. (2013) Current Management of Iron Deficiency Anemia in Inflammatory Bowel Diseases: A Practical Guide. Drugs 73:16, pages 1761-1770.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.